1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Clinical Trial Imaging Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Clinical Trial Imaging Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Clinical Trial Imaging Market Regional Analysis
6.2 North America Clinical Trial Imaging Market Revenue 2021-2028 (US$ Million)
6.3 North America Clinical Trial Imaging Market Forecast Analysis
7. North America Clinical Trial Imaging Market Analysis – by Modality
7.1 Tomography
- 7.1.1 Overview
- 7.1.2 Tomography: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.2 Magnetic Resonance Imaging
- 7.2.1 Overview
- 7.2.2 Magnetic Resonance Imaging: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.3 Ultrasound
- 7.3.1 Overview
- 7.3.2 Ultrasound: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.4 Positron Emission Tomography
- 7.4.1 Overview
- 7.4.2 Positron Emission Tomography: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.5 X-Ray
- 7.5.1 Overview
- 7.5.2 X-Ray: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
7.6 Echocardiography
- 7.6.1 Overview
- 7.6.2 Echocardiography: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
8. North America Clinical Trial Imaging Market Analysis – by Offering
8.1 Operational Imaging Services
- 8.1.1 Overview
- 8.1.2 Operational Imaging Services: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
8.2 Imaging Software
- 8.2.1 Overview
- 8.2.2 Imaging Software: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
8.3 Read Analysis Services
- 8.3.1 Overview
- 8.3.2 Read Analysis Services: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
8.4 Trial Design and Consulting Services
- 8.4.1 Overview
- 8.4.2 Trial Design and Consulting Services: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
9. North America Clinical Trial Imaging Market Analysis – by End User
9.1 Contract Research Organizations
- 9.1.1 Overview
- 9.1.2 Contract Research Organizations: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
9.2 Pharmaceutical and Biotechnology Companies
- 9.2.1 Overview
- 9.2.2 Pharmaceutical and Biotechnology Companies: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
9.3 Academic and Research Institutes
- 9.3.1 Overview
- 9.3.2 Academic and Research Institutes: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: North America Clinical Trial Imaging Market – Revenue and Forecast, 2021-2028 (US$ Million)
10. North America Clinical Trial Imaging Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Clinical Trial Imaging Market Breakdown, by Key
Country, 2024 and 2028 (%)
- 10.2.1.1 North America Clinical Trial Imaging Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 US: North America Clinical Trial Imaging Market Breakdown, by Modality
- 10.2.1.1.2 US: North America Clinical Trial Imaging Market Breakdown, by Offering
- 10.2.1.1.3 US: North America Clinical Trial Imaging Market Breakdown, by End User
- 10.2.1.2 Canada:
North America Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Canada: North America Clinical Trial Imaging Market Breakdown, by Modality
- 10.2.1.2.2 Canada: North America Clinical Trial Imaging Market Breakdown, by Offering
- 10.2.1.2.3 Canada: North America Clinical Trial Imaging Market Breakdown, by End User
- 10.2.1.3 Mexico :
North America Clinical Trial Imaging Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Mexico : North America Clinical Trial Imaging Market Breakdown, by Modality
- 10.2.1.3.2 Mexico : North America Clinical Trial Imaging Market Breakdown, by Offering
- 10.2.1.3.3 Mexico : North America Clinical Trial Imaging Market Breakdown, by End User
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 BioTelemetry Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Calyx Inc
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 eResearch Technology Inc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 ICON PLC
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 IXICO plc
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Medical Metrics Inc
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 Medpace Holdings Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 VIDA Diagnostics Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 WCG Clinical Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations